Deals Today

	Click to View in Browser 04/30/2014 Alstom studies GE offer, leaves door ajar for Siemens PARIS (Reuters) - Cash-strapped French engineering group Alstom said on Wednesday it would study a $16.9 billion offer from General Electric for its energy arm but left the door open for a rival bid from Germany's Siemens. UK lawmakers plan to probe Pfizer pursuit of AstraZeneca LONDON (Reuters) - British lawmakers intend to investigate U.S. drugmaker Pfizer's planned $100 billion takeover of British rival AstraZeneca in a bid to ensure scientific research and jobs are protected. Nuclear power producer Exelon to buy Pepco for $6.83 billion (Reuters) - Exelon Corp, the largest U.S. nuclear power producer, said it would buy Pepco Holdings Inc for $6.83 billion to create the biggest electric and gas utility in the U.S. Mid-Atlantic region. Etihad still open to Alitalia talks, but won't budge on demands MILAN (Reuters) - Etihad Airways has signaled that it is ready to continue talks on a potential investment in Italy's troubled Alitalia but it refuses to budge on tough conditions on debt restructuring and job cuts, a source close to the talks said on Wednesday. India court orders temporary halt on Sun Pharma's $3.2 billion takeover of Ranbaxy MUMBAI (Reuters) - An Indian court has temporarily halted generic drugmaker Sun Pharmaceutical Industries Ltd's $3.2 billion takeover of rival Ranbaxy Laboratories Ltd until it decides on a petition for a probe into alleged insider trading. Battery maker Energizer to split into two (Reuters) - Energizer Holdings Inc said it plans to separate into two publicly traded companies, one for household products and the other for personal care. China approves Merck KGaA's takeover of AZ Electronic BEIJING (Reuters) - China's commerce ministry said on Wednesday it had approved with conditions German liquid crystal maker Merck KGaA's planned $2.6 billion takeover of AZ Electronic Materials . Pfizer may have to pay more cash and top $105 billion to win AstraZeneca LONDON (Reuters) - U.S. drugmaker Pfizer will need to raise its bid for AstraZeneca to around $105-110 billion and increase the proportion of cash in the offer to win its British rival, investors believe. Ex-Rothschild banker Yao faces tough Alibaba IPO test HONG KONG (Reuters) - As Alibaba.com prepared for its Hong Kong IPO in late 2007, details of the deal emerged in local media, much to the frustration of Michael Yao, the company's top financial adviser. Bayer offers animal health assets, cash for Merck's OTC unit -sources FRANKFURT/NEW YORK (Reuters) - Bayer AG is offering to swap its animal health assets for Merck & Co Inc's consumer healthcare business, people familiar with the matter said on Tuesday, in a move that could give the German drugmaker a leg up in the $14 billion auction of the Merck business. Related Video Tougher stress tests may curb bank lending -ECB's Constancio Asia Day Ahead: A May Day check on China factories Related News Euro zone inflation edges up, swift ECB action seen less likely Spain's recovery gains pace but remains hard sell at home A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend